Aramco Ventures

Aramco Ventures is the corporate venture capital arm of Saudi Aramco, operating through multiple fund strategies including its diversified growth fund Prosperity7 Ventures . In the Chinese market, it has surfaced as an active backer of hard-tech and biotech startups: Prosperity7 Ventures led a $63.3 million round for radiopharmaceutical firm Full-Life Technologies in 2024—the first Middle East investment in Chinese biotech that year—and also led CREAO AI's pre-A round of tens of millions of dollars in early 2026, alongside Matrix Partners China and existing investors including Yunqi Capital . Separately, Aramco Ventures made a strategic investment in ZhenFund portfolio company Hyde Hydrogen Energy in late 2024 . Its deployment pattern suggests a focus on energy transition, AI infrastructure, and advanced healthcare, often co-investing with established Chinese VC firms.